A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer-Reference-Cited by-全球学者库

A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer

Published:2022-01-12 Issue:6 Volume:9 Page:2102303
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Hao Qiongyu¹,Huang Zhimin²³,Li Qun⁴,Liu Dingxie⁵,Wang Piwen¹,Wang Kun⁶,Li Jieqing¹⁶,Cao Wei¹,Deng Wenhong¹⁷,Wu Ke¹,Su Rui⁸,Liu Zhongmin⁹,Vadgama Jay¹,Wu Yong¹^ORCID

Affiliation:

1. Division of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USA

2. Key Laboratory of Cell Differentiation and Apoptosis Ministry of Education Department of Pathophysiology Shanghai Jiao‐Tong University School of Medicine Shanghai 200025 China

3. Department of Bioengineering Rice University Houston TX 77005 USA

4. Department of Oncology Shanghai East Hospital School of Medicine Tongji University Shanghai 200123 China

5. Bluewater Biotech LLC New Providence NJ 07974 USA

6. Department of Breast Cancer Cancer Center Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences Guangzhou 510080 China

7. Department of General Surgery Renmin Hospital of Wuhan University Wuhan 430060 China

8. College of Engineering University of California Berkeley CA 94720 USA

9. The Institute for Biomedical Engineering & Nano Science Shanghai East Hospital Tongji University School of Medicine Shanghai 200120 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202102303

Reference58 articles.

1. Diabetes and breast cancer risk: a meta-analysis

2. Diabetes and Cancer: Is Diabetes Causally Related to Cancer?

3. Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus

4. The impact of diabetes on survival following breast cancer

5. Weight gain following breast cancer diagnosis: Implication and proposed mechanisms

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy;Molecules;2024-01-09

2. Advancements in small molecule drug design: A structural perspective;Drug Discovery Today;2023-10

3. Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers;Current Pharmacology Reports;2023-09-18

4. FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer;Breast Cancer Research;2023-08-22

5. Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations;Pharmaceuticals;2023-04-06